Immunoreactivity of Monoclonal Antibody BW835 Represents a Marker of Progression and Prognosis in Early Gastric Cancer

Publisher： Karger

E-ISSN： 1423-0232|61|2|147-155

ISSN： 0030-2414

Source： Oncology, Vol.61, Iss.2, 2001-08, pp. : 147-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 26, Iss. 1, 2003-03 ,pp. : 44-48

Karger

Access to resources Recommend Favorite

miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer

By  

Oncology, Vol. 90, Iss. 4, 2016-03 ,pp. : 221-231

Karger

Access to resources Recommend Favorite

c‐mos immunoreactivity is an indicator of good prognosis in lung cancer

By  

HISTOPATHOLOGY, Vol. 37, Iss. 1, 2000-07 ,pp. : 45-54

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenascin-C Expression Correlates with Prognosis in Gastric Cancer

By  

Oncology, Vol. 64, Iss. 3, 2003-04 ,pp. : 245-250

Karger

Access to resources Recommend Favorite

Prognosis and Surgical Treatment of Gastric Cancer Invading the Pancreas

By  

Oncology, Vol. 59, Iss. 1, 2000-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite